Mesenchymal stem cells encapsulation in chitosan and carboxymethyl chitosan hydrogels to enhance osteo-differentiation

Mol Biol Rep. 2022 Dec;49(12):12063-12075. doi: 10.1007/s11033-022-08013-9. Epub 2022 Oct 31.

Abstract

Background: Recently biomaterials utilized for designing scaffolds in tissue engineering are not cost-effective and eco-friendly. As a result, we design and develop biocompatible and bioactive hydrogels for osteo-tissue regeneration based on the natural polysaccharide chitosan. Three distinct hydrogel components were used for this.

Methods: Hydrogels networks were created using chitosan 2% (CTS 2%), carboxymethyl chitosan 2% (CMC 2%), and 50:50 mixtures of CTS and CMC (CTS/CMC 50:50). Furthermore, scanning electron microscopy (SEM), Fourier transforms infrared spectroscopy (FTIR), degradation, and swelling behavior of design hydrogels were studied. Also, the cytocompatibility and osteo-differentiation potency were examined by encapsulating mesenchymal stem cells derived from adipose tissue (AMSCs) on the designed hydrogels.

Results: According to the findings, our results showed an acceptable pore structure, functional groups, and degradation rate of the designed hydrogels for in vitro evaluation. In addition, employing CMC instead of CTS or adding 50% CMC to the hydrogel component could improve the hydrogel's osteo-bioactivity without the use of external osteogenic differentiation agents.

Conclusion: The CMC-containing hydrogel not only caused early osteogenesis but also accelerated differentiation to the maturity phase of osteoblasts.

Keywords: Bioactivity; Carboxymethyl chitosan; Hydrogel; Osteo-differentiation.

MeSH terms

  • Cell Differentiation
  • Chitosan* / pharmacology
  • Hydrogels / chemistry
  • Hydrogels / pharmacology
  • Mesenchymal Stem Cells* / metabolism
  • Osteogenesis
  • Tissue Engineering / methods
  • Tissue Scaffolds

Substances

  • Hydrogels
  • Chitosan